There are mounting lawsuits against Pfizer, the maker of Lipitor, a drug used to treat high cholesterol. Early this month, plaintiffs who filed Lipitor lawsuits because the drug causes diabetes in women, petitioned the Judicial Panel on Multidistrict Litigation (JPML) to consolidate the pre-trail proceedings for all federal lawsuits. If approved, what does this mean for victims of Lipitor-induced diabetes?
Much research points to the link between a patient’s risk of developing type 2 diabetes and her use of Lipitor. So overwhelming is the evidence that just last year the U.S. Food and Drug Administration (FDA) mandated that Lipitor labels be changed to indicate the risk. Plaintiffs allege that Pfizer knew of the increased risk long before the FDA mandate and failed to warn.
Implications of Consolidation
The petition was presented to the JPML by attorneys representing three plaintiffs in South Carolina. If approved, however, plaintiffs across the country could benefit. In many ways, consolidation could also benefit the defendant and the court system as well. All the lawsuits share common factors. For example, the main question to be answered is whether Pfizer knew that Lipitor greatly increased the risk of type 2 diabetes in women. If they knew, did they adequately warn patients?
The research and documentation to answer those questions will essentially be the same for all plaintiffs. Consolidating the pre-trial proceedings can ensure an efficient process that doesn’t duplicate, wasting court resources and plaintiff’s time. Additionally, consolidation often results in a faster trail and quicker jusitice for the plaintiffs.
How We Can Help
Just because pre-trial proceedings could be consolidated, doesn’t mean your case loses its individuality. Your case is still unique and should be handled as such. Being compensated for something or someone that harmed you shouldn’t be a confusing process. The Levensten Law Firm is closely watching the developments of these cases and the petition to the JPML. If you feel you’ve been harmed by Lipitor, contact us for a free consultation. We’ll keep you up-to-date regarding further developments in these mass tort lawsuits while focusing on your unique situation.